Arbutus Biopharma Corp Live Stock Price Today, Share Analysis and Chart

Name: Arbutus Biopharma Corp: Is Infosys Ltd. worth buying?
Item: Arbutus Biopharma Corp
Rating: 1.55983325
Author: Trendlyne DVM scores

about

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can b...

3.67 0.00 (0.00%)

35.93% Gain from 52W Low

144.6K

XNAS Volume

XNAS 29 Aug, 2025 11:24 AM (EDT)

Not Eligible

Expensive Valuation

6.3 / 100

Technically Neutral

56.1 / 100

1Yr Price target upside is 42%

4 analysts

Arbutus Biopharma Corp Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Arbutus Biopharma Corp Live Stock Price Today, Share Analysis and Chart

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can b...

35.93% Gain from 52W Low

SWOT Analysis

Arbutus Biopharma Corp Live Price Chart